News|Articles|October 31, 2025

Pharmaceutical Executive Presents: Most Favored Nation Order - How Trump Is Disrupting Pharma

Listen

0:00 / 0:00

Key Takeaways

The MFN model, DTC channels, and tariffs are set to transform drug market dynamics, affecting key stakeholders like payers and manufacturers.
The webinar will evaluate if MFN is a sustainable reform or merely a political issue, impacting future healthcare policies.
Proposed payment models GLOBE and GUARD will be analyzed for their potential roles in the evolving drug market landscape.
The real-world impact of tariffs and DTC channels on the pharmaceutical industry will be critically assessed.

Join us for a premium webinar on November 4, 2025!

With Most Favored Nation (MFN) and the emergence of the direct-to-consumer (DTC) model and potential tariffs, traditional roles of payers, pharmacy benefit managers, manufacturers, and 340B hospitals would be fundamentally reshaped.

Exploring the Impacts of MFN, Tariffs and DTC on Drug Markets

On November 4, this exclusive webinar will cut through the political noise and provide a critical, operational analysis of these seismic shifts. We will explore whether MFN is a foundation for permanent reform or simply a political flashpoint, how the proposed mandatory payment models GLOBE and GUARD fit into the future, and what the real-world impact of tariffs and DTC channels will be.

Click here to sign up!

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!